BiotechTube

ONO-2808 + Placebo

Phase 2Active
0 watching 0 views this week⚡ Active
52
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Multiple System Atrophy (MSA)

Conditions

Multiple System Atrophy (MSA)

Trial Timeline

Sep 22, 2023 → Aug 31, 2025

NCT ID
NCT05923866

About ONO-2808 + Placebo

ONO-2808 + Placebo is a phase 2 stage product being developed by Ono Pharmaceutical for Multiple System Atrophy (MSA). The current trial status is active. This product is registered under clinical trial identifier NCT05923866. Target conditions include Multiple System Atrophy (MSA).

Hype Score Breakdown

Clinical
17
Activity
12
Company
10
Novelty
5
Community
5

Clinical Trials (2)

NCT IDPhaseStatus
NCT05923866Phase 2Active
NCT04578028Phase 1Completed

Competing Products

20 competing products in Multiple System Atrophy (MSA)

See all competitors
ProductCompanyStageHype Score
Placebo + PirtobrutinibEli LillyPhase 2
52
Abemaciclib, dexamethasone, ixazomib, pomalidomide + Enasidenib, dexamethasone, ixazomib, pomalidomide + Cobimetinib, dexamethasone, ixazomib, pomalidomide + Erdafitinib, dexamethasone, ixazomib, pomalidomide + Venetoclax, dexamethasone, ixazomib, pomalidomide + Daratumumab, dexamethasone, ixazomib, pomalidomide + Belantamab mafodotin, dexamethasone, ixazomib, pomalidomide + Selinexor, dexamethasone, ixazomib, pomalidomideEli LillyPhase 1/2
41
NEX-20ANanexa ABPhase 1
28
agenT-797MiNK TherapeuticsPhase 1
25
Duloxetine Hydrochloride (HCI) + PlaceboEli LillyPhase 3
77
TemferonGenenta SciencePhase 1/2
33
CT-P44(Daratumumab) + Darzalex Faspro(Daratumumab)CelltrionPhase 3
77
CT-P53 + US-Ocrevus + EU-OcrevusCelltrionPhase 3
77
CS-0777 tablets + CS-0777 tablets + CS-0777 tabletsDaiichi SankyoPhase 1
33
ASP7487, Velcade, DexamethasoneAstellas PharmaPhase 1/2
41
PHE885NovartisPhase 2
52
Mirabegron + PlaceboAstellas PharmaApproved
85
Solifenacin Succinate + Solifenacin Succinate + Oxybutynin Hydrochloride + PlaceboAstellas PharmaApproved
85
Denileukin Diftitox (Ontak)EisaiPhase 1
33
PalonosetronEisaiPhase 2
52
BIW-8962Kyowa KirinPhase 1
33
KRN125(pegfilgrastim), PLR001(plerixafor) + KRN8601(filgrastim), PLR001(plerixafor)Kyowa KirinPhase 2
52
KW-2478 + BortezomibKyowa KirinPhase 1/2
41
KW-2478Kyowa KirinPhase 1
33
ONO-4641 + ONO-4641 + ONO-4641 + ONO-4641 placeboOno PharmaceuticalPhase 2
52

Other Products from Ono Pharmaceutical

Sivelestat sodium hydrate + Sivelestat sodium hydrateApproved
85
Abatacept + Placebo matching with Abatacept + MethotrexateApproved
85
Rivastigmine transdermal patchApproved
85
Sitagliptin phosphatePhase 3
77
ONO-4538 + Carboplatin + Paclitaxel + Bevacizumab + PlaceboPhase 3
77